市場調查報告書

非侵入性產前檢查 (NIPT)的全球市場 - 各檢驗類型·各終端用戶·各地區:市場規模·佔有率·未來展望·機會分析

Non-invasive Prenatal Testing Market, By Test Type, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 968779
出版日期 內容資訊 英文 145 Pages
商品交期: 2-3個工作天內
價格
非侵入性產前檢查 (NIPT)的全球市場 - 各檢驗類型·各終端用戶·各地區:市場規模·佔有率·未來展望·機會分析 Non-invasive Prenatal Testing Market, By Test Type, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年10月12日內容資訊: 英文 145 Pages
簡介

本報告提供全球非侵入性產前檢查 (NIPT)的市場相關分析,提供技術概要和背景情況,市場基本結構及促進·阻礙因素,整體市場規模預測 (以金額為準,過去4年·今後8年份),各檢驗類型·各終端用戶·各地區的詳細趨勢,主要企業的簡介·業績·策略計劃等調查。

目錄

第1章 分析目的·前提條件

第2章 市場概要

  • 分析概要
    • 市場定義和範圍
  • 摘要整理
  • COM (Coherent Opportunity Map:市場機會藍圖)

第3章 市場力學·規定·趨勢分析

  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
  • 影響度分析
  • 近幾年主要的動向
  • 產品銷售
  • PEST分析
  • 技術進步
  • 法規方案
  • 企業合併·收購 (M&A)
  • 新型冠狀病毒感染疾病 (COVID-19)的對市場的影響

第4章 全球非侵入性產前檢查 (NIPT) 市場:各檢驗類型

  • 簡介
    • 市場佔有率分析 (最新值·預測值)
    • 與前一年同期相比成長率 (YoY)的分析 (實際成果值·預測值)
    • 各市場區隔趨勢
  • 面板1試驗
    • 簡介
    • 市場規模與其預測,與前一年同期相比成長率 (YoY) (以金額為準)
  • 面板2試驗
  • 面板3試驗

第5章 全球非侵入性產前檢查 (NIPT) 市場:各終端用戶

  • 簡介
  • 醫院
  • 診斷檢驗室
  • 孕婦中心 (助產設施)

第6章 全球非侵入性產前檢查 (NIPT) 市場:各地區

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第7章 競爭情形

  • 企業簡介
    • Ariosa Diagnostics, Inc.
    • BGI Diagnosis Co., Ltd.
    • Berry Genomics Corporation
    • Illumina, Inc.
    • LifeCodexx AG
    • Natera, Inc.
    • Sequenom, Inc.
    • Natera, Inc.
    • Axia Women's Health
    • Eluthia
    • BillionToOne, Inc.
    • Quest Diagnostics Incorporated

第8章 附錄

目錄

Title:
Non-invasive Prenatal Testing (NIPT) Market, By Test Type (Panel 1 Test, Panel 2 Test, Panel 3 Test), By End User (Hospitals, Diagnostic Laboratories, Maternity Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

  • Non-invasive prenatal testing (NIPT) is a DNA test on maternal blood to screen pregnancies for the most common fetal chromosome anomalies such as trisomy 21 that is Down syndrome, trisomy 18 Edwards syndrome and trisomy 13 Patau syndrome. During non-invasive prenatal testing DNA from the mother and fetus is extracted from maternal blood sample and it is recommended for women who have risk factors for having a baby who has a chromosomal condition. Increasing launches and approvals of new non-invasive prenatal tests (NIPT) along with increasing prevalence of chromosomal disorders is expected to propel the market growth during the forecasted period.

Key features of the study:

  • This report provides in-depth analysis of the Global Non-Invasive Prenatal Testing market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Non-Invasive Prenatal Testing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Ariosa Diagnostics, Inc., BGI Diagnosis Co., Ltd., Berry Genomics Corporation, Illumina, Inc., LifeCodexx AG, Natera, Inc., Sequenom, Inc., Natera, Inc., Axia Women's Health, Eluthia, BillionToOne, Inc., and Quest Diagnostics Incorporated
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Non-Invasive Prenatal Testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Non-Invasive Prenatal Testing market

Detailed Segmentation:

  • Global Non-Invasive Prenatal Testing Market, By Test Type:
    • Panel 1 Test
    • Panel 2 Test
    • Panel 3 Test
  • Global Non-Invasive Prenatal Testing Market, By End User:
    • Hospitals
    • Diagnostic Laboratories
    • Maternity Centers
  • Global Non-Invasive Prenatal Testing Market, By Region:
  • North America
    • By Test Type:
    • Panel 1 Test
    • Panel 2 Test
    • Panel 3 Test
    • By End User
    • Hospitals
    • Diagnostic Laboratories
    • Maternity Centers
    • By Country
    • U.S.
    • Canada
  • Latin America
    • By Test Type:
    • Panel 1 Test
    • Panel 2 Test
    • Panel 3 Test
    • By End User
    • Hospitals
    • Diagnostic Laboratories
    • Maternity Centers
    • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Test Type:
    • Panel 1 Test
    • Panel 2 Test
    • Panel 3 Test
    • By End User
    • Hospitals
    • Diagnostic Laboratories
    • Maternity Centers
    • By Country
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Test Type:
    • Panel 1 Test
    • Panel 2 Test
    • Panel 3 Test
    • By End User
    • Hospitals
    • Diagnostic Laboratories
    • Maternity Centers
    • By Country
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Test Type:
    • Panel 1 Test
    • Panel 2 Test
    • Panel 3 Test
    • By End User
    • Hospitals
    • Diagnostic Laboratories
    • Maternity Centers
    • By Country
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • By Test Type:
    • Panel 1 Test
    • Panel 2 Test
    • Panel 3 Test
    • By End User
    • Hospitals
    • Diagnostic Laboratories
    • Maternity Centers
    • By Country
    • North Africa
    • Central Africa
    • South Africa
  • Company Profiles
  • Ariosa Diagnostics, Inc. *
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • BGI Diagnosis Co., ltd.
  • Berry Genomics Corporation
  • Illumina, Inc.
  • LifeCodexx AG
  • Natera, Inc.
  • Sequenom, Inc.
  • Natera, Inc.
  • Axia Women's Health
  • Eluthia
  • BillionToOne, Inc.
  • Quest Diagnostics Incorporated
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Test Type
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions
  • COVID19 Impact on the market

4. Global Non-Invasive Prenatal Testing Market, By Test Type, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Panel 1 Test
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Panel 2 Test
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Panel 3 Test
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

5. Global Non-Invasive Prenatal Testing Market, By End User, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Maternity Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Non-Invasive Prenatal Testing Market, By Region, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

  • Company Profiles
    • Ariosa Diagnostics, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • BGI Diagnosis Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Berry Genomics Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Illumina, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • LifeCodexx AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Natera, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sequenom, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Natera, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Axia Women's Health
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Eluthia
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • BillionToOne, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Quest Diagnostics Incorporated
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact